273 related articles for article (PubMed ID: 23590927)
41. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
Honer WG; Kopala LC; Rabinowitz J
J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
[TBL] [Abstract][Full Text] [Related]
42. [Risperidone in the early treatment of first-episode psychosis: a two-year follow-up study].
Gutiérrez Fraile M; Segarra Echevarría R; González-Pinto Arrillaga A; Martínez Junquera G
Actas Esp Psiquiatr; 2002; 30(3):142-52. PubMed ID: 12106515
[TBL] [Abstract][Full Text] [Related]
43. Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis.
Lambert M; Conus P; Cotton S; Robinson J; McGorry PD; Schimmelmann BG
J Clin Psychopharmacol; 2010 Oct; 30(5):565-72. PubMed ID: 20814327
[TBL] [Abstract][Full Text] [Related]
44. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.
Machielsen M; van der Sluis S; de Haan L
Aust N Z J Psychiatry; 2010 Aug; 44(8):721-8. PubMed ID: 20636193
[TBL] [Abstract][Full Text] [Related]
45. Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort.
Setién-Suero E; Neergaard K; Ortiz-García de la Foz V; Suárez-Pinilla P; Martínez-García O; Crespo-Facorro B; Ayesa-Arriola R
Acta Psychiatr Scand; 2019 Oct; 140(4):349-359. PubMed ID: 31381129
[TBL] [Abstract][Full Text] [Related]
46. Long-term trajectories of positive and negative symptoms in first episode psychosis: A 10year follow-up study in the OPUS cohort.
Austin SF; Mors O; Budtz-Jørgensen E; Secher RG; Hjorthøj CR; Bertelsen M; Jeppesen P; Petersen L; Thorup A; Nordentoft M
Schizophr Res; 2015 Oct; 168(1-2):84-91. PubMed ID: 26265299
[TBL] [Abstract][Full Text] [Related]
47. Cannabis using schizophrenia patients treated with atypical neuroleptics: do their symptoms differ from those of cannabis abstainers?
Schaub M; Fanghaenel K; Senn C; Stohler R
Subst Use Misuse; 2008 Dec; 43(14):2045-52. PubMed ID: 19085437
[TBL] [Abstract][Full Text] [Related]
48. Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation.
Stone JM; Fisher HL; Major B; Chisholm B; Woolley J; Lawrence J; Rahaman N; Joyce J; Hinton M; Johnson S; Young AH;
Psychol Med; 2014 Feb; 44(3):499-506. PubMed ID: 23701858
[TBL] [Abstract][Full Text] [Related]
49. A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness.
Madigan K; Brennan D; Lawlor E; Turner N; Kinsella A; O'Connor JJ; Russell V; Waddington JL; O'Callaghan E
Schizophr Res; 2013 Jan; 143(1):138-42. PubMed ID: 23187069
[TBL] [Abstract][Full Text] [Related]
50. Insight correlates in child- and adolescent-onset first episodes of psychosis: results from the CAFEPS study.
Parellada M; Fraguas D; Bombín I; Otero S; Castro-Fornieles J; Baeza I; Gonzalez-Pinto A; Graell M; Soutullo C; Paya B; Arango C
Psychol Med; 2009 Sep; 39(9):1433-45. PubMed ID: 19091160
[TBL] [Abstract][Full Text] [Related]
51. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
52. Does giving up substance use work for patients with psychosis? A systematic meta-analysis.
Mullin K; Gupta P; Compton MT; Nielssen O; Harris A; Large M
Aust N Z J Psychiatry; 2012 Sep; 46(9):826-39. PubMed ID: 22368242
[TBL] [Abstract][Full Text] [Related]
53. Cigarette smoking and cannabis use are equally strongly associated with psychotic-like experiences: a cross-sectional study in 1929 young adults.
van Gastel WA; MacCabe JH; Schubart CD; Vreeker A; Tempelaar W; Kahn RS; Boks MP
Psychol Med; 2013 Nov; 43(11):2393-401. PubMed ID: 23414608
[TBL] [Abstract][Full Text] [Related]
54. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
[TBL] [Abstract][Full Text] [Related]
55. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
56. No additive effect of cannabis on cognition in schizophrenia.
Power BD; Dragovic M; Badcock JC; Morgan VA; Castle D; Jablensky A; Stefanis NC
Schizophr Res; 2015 Oct; 168(1-2):245-51. PubMed ID: 26235754
[TBL] [Abstract][Full Text] [Related]
57. Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences.
Setién-Suero E; Neergaard K; Ramírez-Bonilla M; Correa-Ghisays P; Fañanás L; Crespo-Facorro B; Ayesa-Arriola R
PLoS One; 2017; 12(8):e0183613. PubMed ID: 28832666
[TBL] [Abstract][Full Text] [Related]
58. Neuropsychological assessment of memory in child and adolescent first episode psychosis: cannabis and «the paradox effect».
Moreno-Granados JM; Ferrín M; Salcedo-Marín DM; Ruiz-Veguilla M
Rev Psiquiatr Salud Ment; 2014; 7(1):13-24. PubMed ID: 23830215
[TBL] [Abstract][Full Text] [Related]
59. Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis.
Barrigón ML; Gurpegui M; Ruiz-Veguilla M; Diaz FJ; Anguita M; Sarramea F; Cervilla J
J Psychiatr Res; 2010 May; 44(7):413-20. PubMed ID: 19900684
[TBL] [Abstract][Full Text] [Related]
60. Cannabis use and psychosis: a longitudinal population-based study.
van Os J; Bak M; Hanssen M; Bijl RV; de Graaf R; Verdoux H
Am J Epidemiol; 2002 Aug; 156(4):319-27. PubMed ID: 12181101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
